Therapeutic Venesection in Melbourne
Therapeutic venesection is a procedure in which a measured amount of blood is removed to reduce excess iron or an abnormally high red blood cell mass. It is similar to donating blood, but it is prescribed as medical treatment and the frequency is based on blood tests and the underlying diagnosis. The two most common reasons are hereditary haemochromatosis with iron overload and polycythaemia vera or selected other causes of erythrocytosis.
Specialist assessment matters because not every high ferritin represents iron overload and not every high haemoglobin should be treated by removing blood.
In hereditary haemochromatosis, increased intestinal iron absorption can gradually cause excess iron to accumulate. Venesection removes red cells that contain iron, prompting the body to use stored iron to make replacement red cells. During an initial depletion phase, treatment may be relatively frequent until ferritin falls into a target range. Maintenance venesection is then performed less often according to how quickly iron reaccumulates. Haemoglobin is checked to make sure treatment is not causing anaemia.
Polycythaemia vera is a myeloproliferative neoplasm in which the bone marrow produces too many red cells, often because of an acquired JAK2 mutation. A high haematocrit increases blood viscosity and is associated with thrombosis risk. Venesection is used to keep the haematocrit within a target range, often alongside low-dose aspirin and, for higher-risk patients, medication that suppresses blood cell production. The treatment plan also addresses cardiovascular risk factors and symptoms such as headache, itch or microvascular disturbance.
An elevated haemoglobin can result from smoking, chronic lung disease, sleep apnoea, testosterone therapy, kidney conditions, dehydration or living at altitude. This is often called secondary erythrocytosis. The underlying cause is usually more important than the number itself, and routine venesection is not required for every patient. The haematologist determines whether there is evidence of a myeloproliferative disorder, whether symptoms are attributable to hyperviscosity and whether venesection is likely to provide a net benefit.
Before venesection, blood pressure, symptoms and a recent blood count are reviewed. A cannula or large needle is inserted into a vein and a prescribed volume of blood is removed. Patients are encouraged to be well hydrated unless they have a medical reason to restrict fluids. Temporary light-headedness, fatigue or bruising can occur. The frequency is adjusted according to ferritin and transferrin saturation for iron overload or haemoglobin/haematocrit for erythrocytosis.
High ferritin requires interpretation before venesection is started. Ferritin can rise because of inflammation, fatty liver, alcohol use or metabolic conditions without true excess body iron. Transferrin saturation, HFE genotype, liver tests and sometimes MRI-based liver iron assessment help distinguish these causes.
For erythrocytosis, repeated blood counts confirm that the elevation is persistent. Erythropoietin levels, JAK2 testing and assessment for hypoxia or sleep apnoea may be appropriate. A bone marrow biopsy is used selectively when the diagnosis of a myeloproliferative neoplasm remains uncertain or when additional information is required.
Venesection is most effective when it is part of a broader disease plan. Patients with haemochromatosis may also need assessment of liver health and advice about avoiding unnecessary iron supplements. Patients with polycythaemia vera require ongoing monitoring for thrombosis, symptoms and changes in other blood cell lines.
Northern Blood & Cancer Care can provide the specialist oversight needed to set the treatment target, prescribe the appropriate frequency and decide when venesection should be paused. This prevents the procedure from becoming an automatic response to a laboratory number without continued review of the underlying condition.
Specialist appointments are most useful when the reason for referral is clear and previous investigations are available for comparison. If treatment is recommended, the specialist will discuss the intended goal, expected benefit, important risks and reasonable alternatives. Decisions are revisited if results, symptoms or personal circumstances change. Patients should contact the clinic if they are unsure whether a new symptom can wait until the next scheduled review; urgent or severe symptoms may require assessment through an emergency service rather than a routine outpatient appointment.
The Haematology specialists associated with this service include:
Northern Blood & Cancer Care provides specialist oversight of venesection for haemochromatosis, polycythaemia vera and selected other conditions. The team first confirms why ferritin, haemoglobin or haematocrit is elevated, then sets an appropriate treatment target and monitoring plan so venesection is used as part of evidence-based disease management rather than simply in response to a laboratory number.
Northern Blood & Cancer Care brings together a highly experienced team of haematologists, medical oncologists and specialist physicians, with consultations available at Northern Private Hospital in Epping.
Contact our team to arrange an appointment or discuss a referral.
